|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Ob: Aneuploidy screeningFrom: Jane Helwig, MD (jane@helwig.net)Tue Jul 25 11:25:08 2006
I know of a case where a patient had sickle cell trait. She was counseled appropriately to have the father of the baby come in for a blood draw for hemoglobin electrophoresis. The risk of sickle cell disease in the baby was discussed and this discussion was documented. The father of the baby never came in, the baby was born and had sickle cell disease, a lawsuit was filed, and a settlement was reached. The plaintiff (via her lawyers) said that she wasn't told that she could have had amniocentesis to find out if the baby had sickle cell disease. She said that if she had known this, she would have had amniocentesis and would have aborted a fetus with SCD. So it's not enough to try to get the FOB in for blood draw when the patient has sickle cell trait. You must also document that you offered amniocentesis for diagnosis of sickle cell disease. And I guess this would extend to cystic fibrosis carrier testing when the mom is a carrier and the FOB doesn't or won't come in, or when the patient isn't sure who the FOB is.
-- Jane Helwig, MD, FACOG moving at the moment...
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Tue Sep 2 05:08:13 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.